Clene Inc

Research Clene Inc (CLNN) on Bullrun: market cap USD 74.62M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLNN
• ExchangeNASDAQ
• CountryUnited States
• SectorConsumer Defensive
• IndustryPackaged Foods
• CurrencyUSD
• Market capUSD 74.62M
• Financial periodFY2025
• RevenueUSD 200.00K
• Revenue growth-41.5%
• Net income-USD 26.17M
• Free cash flow-USD 18.59M
• Gross margin78.5%

Valuation Snapshot

latest market cap is USD 74.62M.

About Clene Inc

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS;

Frequently asked questions

What is Clene Inc's market cap?

Clene Inc's market capitalization is USD 74.62M.

What does Clene Inc do?

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.